Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)
Latest Information Update: 24 Aug 2023
At a glance
- Drugs Temoporfin (Primary)
- Indications Cholangiocarcinoma
- Focus Adverse reactions
- 20 Aug 2023 Status changed from recruiting to completed.
- 27 Jan 2021 Planned End Date changed from 30 Aug 2023 to 30 Aug 2024.
- 27 Jan 2021 Planned primary completion date changed from 30 Aug 2022 to 30 Aug 2023.